From: Centrosome associated genes pattern for risk sub-stratification in multiple myeloma
Stratification group | N | HR (95 % CI) | Survival median (months) | 3-years outcome (%) | p value (log-rank) |
---|---|---|---|---|---|
Overall survival | |||||
Low risk CAGP | 66 | 38.8 | 53.8 | <0.00799 | |
High risk CAGP | 84 | 1.8 (1.16; 2.80) | 22.1 | 25.1 | |
IMWG standard risk | 41 | 22.8 | 32.1 | <0.1371 | |
IMWG high risk | 28 | 1.6 (0.86; 2.91) | 15.8 | 23.5 | |
IMWG standard risk/low risk CAGP | 18 | 29.2 | 42.9 | <0.4532 | |
IMWG standard risk/high risk CAGP | 23 | 1.4 (0.59; 3.25) | 22.8 | 27.4 | |
IMWG high risk/low risk CAGP | 14 | 16.6 | 49.9 | <0.02836 | |
IMWG high risk/high risk CAGP | 14 | 2.8 (1.07; 7.45) | 11.5 | 8.2 | |
Time to progression | |||||
Low risk CAGP | 66 | 13.6 | 11.5 | <0.1939 | |
High risk CAGP | 84 | 1.3 (0.88; 1.88) | 13.0 | 8.7 | |
IMWG standard risk | 41 | 13.2 | 6.9 | <0.7824 | |
IMWG high risk | 28 | 1.1 (0.62; 1.89) | 12.0 | 0 | |
IMWG Standard risk/low risk CAGP | 18 | 12.3 | 0 | <0.9978 | |
IMWG standard risk/high risk CAGP | 23 | 1 (0.48; 2.07) | 14.5 | 9.6 | |
IMWG high risk/low risk CAGP | 14 | 17.7 | 0 | <0.05469 | |
IMWG high risk/high risk CAGP | 14 | 2.3 (0.96; 5.55) | 8.0 | 0 | |
Progression free survival | |||||
Low risk CAGP | 66 | 12.6 | 10.8 | <0.06232 | |
High risk CAGP | 84 | 1.4 (0.98; 2.03) | 10.2 | 5.6 | |
IMWG standard risk | 41 | 13.2 | 6.3 | <0.8121 | |
IMWG high risk | 28 | 1.1 (0.62; 1.84) | 11.4 | 0 | |
IMWG standard risk/low risk CAGP | 18 | 12.3 | 0 | <0.9395 | |
IMWG standard Risk/high risk CAGP | 23 | 1 (0.48; 1.97) | 13.9 | 9.1 | |
IMWG high risk/low risk CAGP | 14 | 17.7 | 0 | <0.0325 | |
IMWG high risk/high risk CAGP | 14 | 2.5 (1.05; 5.89) | 7.7 | 0 |